Abstract
Limited data are available concerning long-term prostate cancer (PCa)-related medical costs for use in assessing PCa prevention strategies. The aim of this study was to examine treatment, long-term survival, and long-term PCa-related costs by cancer stage. Costs in phases of care based on the natural history of PCa were also examined. Our data illustrate that initial care is characteristic of a rapid rate of cost accrual. This rate then decreases during continuing care. For terminal care, only stage IV resumes a rate of cost accrual similar to initial care. With average PCa-related costs of $18 168 observed over an average follow-up of 4 years, prevention strategies may result in a reduction in medical costs.
Original language | English (US) |
---|---|
Pages (from-to) | 278-284 |
Number of pages | 7 |
Journal | Prostate Cancer and Prostatic Diseases |
Volume | 13 |
Issue number | 3 |
DOIs | |
State | Published - Sep 2010 |
Keywords
- Health-care costs
- Prostate cancer
- Survival
- Utilization
ASJC Scopus subject areas
- Oncology
- Urology
- Cancer Research